The potential of oligonucleotides for therapeutic applications.
about
Noble metal nanoparticles applications in cancerDeNAno: Selectable deoxyribonucleic acid nanoparticle libraries.Isolation of DNA aptamers using micro free flow electrophoresisMolecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates.Structure-based DNA-targeting strategies with small molecule ligands for drug discovery.Possibilities for RNA interference in developing hepatitis C virus therapeutics.Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis.Robust suppression of HIV replication by intracellularly expressed reverse transcriptase aptamers is independent of ribozyme processing.Synthetic RNA circuits.DNA-binding drugs caught in action: the latest 3D pictures of drug-DNA complexes.CELL-SELEX: Novel perspectives of aptamer-based therapeutics.Isolating single stranded DNA using a microfluidic dialysis device.Genes in sport and doping.DNA-based nanostructures for molecular sensing.Unlocked nucleic acid--an RNA modification with broad potential.Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.Aptamer-dendrimer bioconjugate: a nanotool for therapeutics, diagnosis, and imaging.Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine.In vitro selection and characterization of cellulose-binding RNA aptamers using isothermal amplificationFuran oxidation based cross-linking: a new approach for the study and targeting of nucleic acid and protein interactions.Specificity protein 1 and Smad-dependent regulation of human heme oxygenase-1 gene by transforming growth factor-beta1 in renal epithelial cells.Triplex crosslinking through furan oxidation requires perturbation of the structured triple-helix.Stabilizing the code-methods to preserve RNA prove their worth.The effect of an oligonucleotide on the structure of cationic DODAB vesicles.Somatic mosaicism with reversion to normality of a mutated transthyretin allele related to a familial amyloidotic polyneuropathy.Structural insights on biologically relevant cationic membranes by ESR spectroscopy.Gene Silencing Using Multifunctionalized Gold Nanoparticles for Cancer Therapy.Metal-organic frameworks for precise inclusion of single-stranded DNA and transfection in immune cells.Bis-Pyrene-Modified Unlocked Nucleic Acids: Synthesis, Hybridization Studies, and Fluorescent Properties
P2860
Q21284977-0D4FA8E1-A756-4C4B-9DA6-BA944869725BQ30956621-1D9AC87A-6529-4C65-B36A-F5FB00184046Q34030440-7B26C0B7-8582-45DD-85A0-FAEF2E2AEEB0Q34076231-C5BE2BBE-0895-404D-99AD-EB4231F5B869Q34697484-5382D1F5-CD20-4489-B66C-3D41E07F21FCQ35261143-0670FD69-1E2E-47AD-AD54-0F5073BB9A0CQ35865494-C53CEB6B-D0E6-4184-BD78-1655EAC063D1Q36460462-49FB4B76-7372-4994-B3ED-022E0B690148Q36685861-921CA1F6-B31E-4B41-A0EE-264DFFF1DC05Q37362257-977FDE8B-C764-4C8F-A4EF-9DC54644C95CQ37424823-5AABA504-28D7-4F7E-9EF2-9EA2A49F8702Q37483203-3A5BEE93-C2C9-4EC0-8D66-98E7C8A2A56DQ37621203-34B76EC8-F408-4952-AED9-71ADF90FE4BDQ37774254-8F3ED340-4630-4C64-85A1-6E4D5FE25C4BQ37856768-F605D235-0DF8-490A-90D7-FF44361C1C6AQ37864925-BAE722F5-FD5C-4942-B834-8233E2C00684Q38035033-5D8F30EB-F7B5-44AA-85F6-1B22C12C58F7Q38235410-E1EAFCAB-B2DE-448A-B93A-7AF3F35F7078Q38288349-73C18B15-CBE7-4268-A404-EB8062B92F98Q38294713-F820F622-1442-49A4-8DF6-94BE332DBB6AQ38300840-182F6C65-32B2-4034-A9E9-1B449ED51BACQ38301400-B22369B3-7AE1-4C9D-BC9E-3CC4C6B64278Q41104381-54EDEF07-3B50-4DF0-BD3D-C0FCC79476FBQ41367658-BB0DF461-98A2-4E25-BE66-72113C139719Q45867751-8AB32B77-EC06-4FA4-9DEE-3B837837BFBAQ47115771-55759201-38A7-4EEB-8143-22503DF3C36CQ48848435-1F5B4C17-DC16-4421-94F5-69FE2F70427BQ52609000-AF10C47E-1E6C-4279-B8B3-E7C5CAFCAA66Q59003811-8159404B-C22F-43BA-A09C-7FFC19F76D2B
P2860
The potential of oligonucleotides for therapeutic applications.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The potential of oligonucleotides for therapeutic applications.
@ast
The potential of oligonucleotides for therapeutic applications.
@en
The potential of oligonucleotides for therapeutic applications.
@nl
type
label
The potential of oligonucleotides for therapeutic applications.
@ast
The potential of oligonucleotides for therapeutic applications.
@en
The potential of oligonucleotides for therapeutic applications.
@nl
prefLabel
The potential of oligonucleotides for therapeutic applications.
@ast
The potential of oligonucleotides for therapeutic applications.
@en
The potential of oligonucleotides for therapeutic applications.
@nl
P1476
The potential of oligonucleotides for therapeutic applications.
@en
P2093
Claude Férec
Yann Fichou
P304
P356
10.1016/J.TIBTECH.2006.10.003
P577
2006-10-12T00:00:00Z